Advertisement
Advertisement

CANF

CANF logo

Can-Fite BioPharma Ltd. - ADR

3.51
USD
Sponsored
-0.03
-0.85%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

3.52

+0.01
+0.37%

Can-Fite BioPharma Ltd. - ADR Profile

About

Can Fite Biopharma Ltd. is a biopharmaceutical company. It is focused on developing drugs for the treatment of cancer and autoimmune inflammatory diseases. The Company's lead drug candidate, CF101, is in clinical development for the treatment of autoimmune inflammatory diseases. Its CF102 drug candidate is being developed for the treatment of liver diseases and its CF602 drug is being developed for the treatment of inflammation and sexual dysfunction. Can Fite Biopharma Ltd. is based in Petach Tikva, Israel.

Info & Links

CEO

Motti Farbstein

Headquarters

26 BEN GURION STREET
RAMAT GAN, L3 5257346, ISRAEL

Industry

Medical Drugs

Sector

Medical

Website

www.canfite.com

Auditor

KOST FORER GABBAY& KASIERER

Share holders

--

Employees

5

Can-Fite BioPharma Ltd. - ADR Statistics

Valuation Measures

Market Capitalization2

7.55M

Enterprise Value

2.02M

Enterprise Value/EBITDA(ttm)

-0.74

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.69

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-325.25%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-30.02%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

196.00K

Revenue Per Share(ttm)

0.15

Gross Profit(ttm)

196.00K

EBITDA(ttm)3

-2.71M

Net Income Available to Common(ttm)

-2.55M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.06

52-Week Change

-84.26%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

650.00K

% Held by Insiders

0.80%

% Held by Institutions

21.00%

Balance Sheet

Total Cash(mrq)

--

Total Cash Per Share(mrq)

--

Total Debt(mrq)

--

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

3.46%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement